Alto Neuroscience Q1 2024 GAAP EPS $(0.76) Misses $(0.47) Estimate
Portfolio Pulse from Benzinga Newsdesk
Alto Neuroscience reported a Q1 2024 GAAP EPS of $(0.76), missing the consensus estimate of $(0.47) by 61.7%.
May 14, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Alto Neuroscience's Q1 2024 earnings report showed a significant miss against analyst expectations, with a GAAP EPS of $(0.76) compared to the estimated $(0.47).
Earnings misses typically lead to negative investor sentiment in the short term, potentially causing a decrease in stock price as expectations are adjusted downwards.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100